BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10352 related articles for article (PubMed ID: 15492467)

  • 1. Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation.
    Zhang CL; Wu LJ; Zuo HJ; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2004 Oct; 96(2):155-63. PubMed ID: 15492467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome.
    Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
    J Asian Nat Prod Res; 2004 Jun; 6(2):127-38. PubMed ID: 15008459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells.
    Liu YQ; You S; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2005 Aug; 98(4):361-71. PubMed ID: 16079470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
    Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH
    Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas/FasL signaling allows extracelluar-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells.
    Liu YQ; Mu ZQ; You S; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2006 Sep; 29(9):1873-9. PubMed ID: 16946501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oridonin induced U937 cell apoptosis through ERK pathway].
    Liu YQ; You S; Tashiro S; Onodera S; Ikejima T
    Zhongguo Zhong Yao Za Zhi; 2005 Dec; 30(23):1856-9. PubMed ID: 16499027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
    Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
    J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929.
    Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2004 Oct; 27(10):1527-31. PubMed ID: 15467189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells.
    Li D; Cui Q; Chen SG; Wu LJ; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2007 Sep; 105(1):22-33. PubMed ID: 17895587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin induces human melanoma A375-S2 cell death partially through inhibiting insulin-like growth factor 1 receptor signaling.
    Wang HJ; Li D; Yang FY; Tashiro S; Onodera S; Ikejima T
    J Asian Nat Prod Res; 2008; 10(7-8):787-98. PubMed ID: 18696333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways.
    Huang J; Wu L; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2008 Aug; 107(4):370-9. PubMed ID: 18719315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 up-regulation and P-p53 down-regulation account for the low sensitivity of murine L929 fibrosarcoma cells to oridonin-induced apoptosis.
    Huang J; Wu L; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2005 Nov; 28(11):2068-74. PubMed ID: 16272691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
    Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
    Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway.
    Li D; Wu LJ; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2007 Jan; 103(1):56-66. PubMed ID: 17251686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway.
    Sun KW; Ma YY; Guan TP; Xia YJ; Shao CM; Chen LG; Ren YJ; Yao HB; Yang Q; He XJ
    World J Gastroenterol; 2012 Dec; 18(48):7166-74. PubMed ID: 23326121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
    Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
    Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
    Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin Inhibits Cell Proliferation and Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.
    Shang CH; Zhang QQ; Zhou JH
    Inflammation; 2016 Apr; 39(2):873-80. PubMed ID: 26923246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-2 suppresses oridonin-induced L929 apoptosis through extracellular signal-regulated kinase-dependent and phosphatidylinositol 3-kinase-independent pathway.
    Huang J; Wu L; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2006 Nov; 102(3):305-13. PubMed ID: 17116975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 518.